Clinical Trials Browser

Phase 1 × Carcinoma, Ovarian Epithelial × GEN-1 × Clear all

NCT02480374 2024-10-02

Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer

Phase 1 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms